Pharma ingredients
-
Ganirelix Acetate peptide API
Nomen: Ganirelix acetate
Cas Number: 123246-29-7
Molecular formula: c80h113cln18o13
M. pondus: 1570.34
-
Linaclotide enim gastrointestinal perturbationes 851199-59-2
Nomen Linaclotide
Cas Number: 851199-59-2
Molecular Formula: C59H79N15O21S6
M. pondus: 1526,74
-
Semaglutide ad Type II diabete
Nomen: semaglutide
Cas Number: 910463-68-2
Molecular Formula: c187h291n45o59
M. pondus: 4113,57754
Einecs Number: 203-405-2
-
1- (IV-methoxyphen) methanamine
Potest adhiberi ad synthesis de pharmaceutical intermedia. Paulo nocet aqua. Ne merito vel magna quantitates venient in contactum cum groundwater, waterways aut purgamentorum systems. Sine imperio permission, non seminis materiae in ambiente environment ad vitare oxides, acida. , Aeris, carbo carbonis dioxide contactus, ut continens signatus, posuit in stricta extractor, et copia in a frigus, siccum est.
-
2,6-Dihydroxy-III-Cyano-IV-methyl pyridine
CAS non.: 5444-02-0
MOLECULA: C7H6N2O2
M. pondus: 150.13
Einecs: 226-639-7
Melting Point: CCCXV ° C (Dec.) (Gen.)
Fervens Point: 339.0 ± 42.0 ° C (praedicta)
Density: 1.38 ± 0.1 G / CM3 (praedicta)
Acidited coefficiens: (Pka) 3.59 ± 0.58 (praedicta)
-
Conventional amino acidum seriem
No.
Productus
Cas No.
Applicatio
1
Fmoc, Arg (PBF) -OH 154445-77-9 Maxime peptides
2
FMOC, ASN (TT) -OH 13388-59-1 Maxime peptides
3
Fmoc-ASP (otbu) -ohh 71989-14-5 Maxime peptides
-
D-amino acida series solidum tempus synthesis
No
Productus
Cas No.
1
FMOC-3 (II-Naphthyl) -D-Ala 138774-94-4 2
AC-3- (II-Naphthyl) -D-Ala-O 37440-01-0 3
FMOC-3 (III-Pyridinyl) -D-ALA-O 142994-45-4 -
GLP-I protected amino acidum latus catenam modificationem
Non.
Productus
Cas No.
1
Fmoc, Lys (MTT) -OH 167393-62-6 2
Fmoc, lys (Alloc) -oh 146982-27-6 3
Fmoc, lys (ivdde) -ohh 150629-67-7 4
Fmoc, lys (MMT) -ohh 159857-60-0 -
Gnrh Anagonist propter Peptides synthesis
NO
Productus
Cas No.
Applicatio
1
AC-3- (II-Naphthyl) -D-Ala-O
37440-01-0
Maxime products
2
FMOC-3 (III-Pyridinyl) -D-ALA-O
142994-45-4
Maxime products
3
Fmoc-IV-chloro-d-phe-oh
142994-19-2
Maxime products
-
Impura of Amino Acidum propter synthesize dapibus
NO
Productus
Cas non
1
Fmoc-D-Ala-D-Ala
NA
2
Fmoc-β-Ala-D-Ala
NA
3
Fmoc, Arg (PBF) -arg (PBF) -oh
NA
-
Alii protected amino acida ad disulfide vinculum
NO
Productus
Cas non
Applicatio
1
Fmoc-CYS (MMT) -OH
177582-21-7
Disulfide vinculum
2
Fmoc-cys (IV-allylbutyrate) -oh
/
Disulfide vinculum
3
MPA (TT) -OH
27144-18-9
Finis sequentia
-
Paclitaxel 33069-62-4 anti-tumor botanical medicina ad ovarian cancer, pectus cancer
Melting Point: CCXIII °
Fervens Point: 774,66 ° C (aspera estimate)
Specific Rotation: D20 -49 ° (Methanol)
Density: 1.0352 (aspera estimate)
Flash Point: IX ° F
Repono conditionibus: 2-8 °
Forma: Pulveris
Acidited coefficient: 11.90 ± 0.20 (praedicta)
Color alba